Compounds > 1-(3-c-ethynylribopentofuranosyl)uracil
Page last updated: 2024-09-05

1-(3-c-ethynylribopentofuranosyl)uracil and dacarbazine

1-(3-c-ethynylribopentofuranosyl)uracil has been researched along with dacarbazine in 1 studies

Compound Research Comparison

Studies
(1-(3-c-ethynylribopentofuranosyl)uracil)		Trials
(1-(3-c-ethynylribopentofuranosyl)uracil)		Recent Studies (post-2010)
(1-(3-c-ethynylribopentofuranosyl)uracil)		Studies
(dacarbazine)		Trials
(dacarbazine)		Recent Studies (post-2010) (dacarbazine)
11027,5561,4633,429

Protein Interaction Comparison

ProteinTaxonomy1-(3-c-ethynylribopentofuranosyl)uracil (IC50)dacarbazine (IC50)
Matrix metalloproteinase-9Homo sapiens (human)0.556

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, H; Echizenya, S; Fujii, Y; Ichikawa, S; Isogawa, M; Kondo, T; Maenaka, K; Matsuda, A; Natsumeda, M; Ogura, R; Ohtsu, N; Otsuguro, S; Sakaitani, M; Tsukamoto, Y1

Other Studies

1 other study(ies) available for 1-(3-c-ethynylribopentofuranosyl)uracil and dacarbazine

ArticleYear
Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating Cells.
    Stem cells (Dayton, Ohio), 2016, Volume: 34, Issue:8

    Topics: 5'-Nucleotidase; Animals; Brain Neoplasms; Carcinogenesis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Dacarbazine; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Glioblastoma; Glycoproteins; Humans; Mice, SCID; Temozolomide; Uracil; Uridine

2016